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http://dx.doi.org/10.1016/j.stemcr.2016.04.015SUMMARYEmbryonic stem cells (ESCs) are a hallmark of ideal pluripotent stem cells. Epigenetic reprogramming of induced pluripotent stem cells
(iPSCs) has not been fully accomplished. iPSC generation is similar to somatic cell nuclear transfer (SCNT) in oocytes, and this procedure
can be used to generate ESCs (SCNT-ESCs), which suggests the contribution of oocyte-specific constituents. Here, we show that the
mammalian oocyte-specific linker histone H1foo has beneficial effects on iPSC generation. Induction of H1foo with Oct4, Sox2, and
Klf4 significantly enhanced the efficiency of iPSC generation. H1foo promoted in vitro differentiation characteristics with low hetero-
geneity in iPSCs. H1foo enhanced the generation of germline-competent chimeric mice from iPSCs in a manner similar to that for
ESCs. These findings indicate that H1foo contributes to the generation of higher-quality iPSCs.INTRODUCTION
Induced pluripotent stem cells (iPSCs) can be generated
from somatic cells by introducing Oct4, Sox2, Klf4,
and c-Myc (Takahashi and Yamanaka, 2006). This can be
achieved by reprogramming the transcription network
and epigenetic signature of the parental somatic cells.
iPSCs have several benefits for basic research, drug innova-
tion, and regeneration therapy. However, recent studies
have reported genetic and epigenetic variations with iPSCs
(Hussein et al., 2011; Kim et al., 2010; Polo et al., 2010; Ruiz
et al., 2012; Stadtfeld et al., 2010; Taapken et al., 2011),
which influences gene expression and could lead to func-
tional diversity within iPSC replicates (Liang and Zhang,
2013). In fact, several studies have reported the heteroge-
neous differentiation potential among generated iPSC
clones compared with those of embryonic stem cells
(ESCs) (Feng et al., 2010; Hu et al., 2010; Narsinh et al.,
2011). It is important that every iPSC clone shows high
quality without variation for basic research and clinical
purposes. Many attempts have been made to solve these
problems by various methods (Gafni et al., 2013), but not
all iPSCs exhibit quality as high as that of ESCs.
The reprogramming of somatic cells was originally
demonstrated by producing cloned frogs using somatic
cell nuclear transfer (SCNT) into Xenopus oocytes (GurdonStem C
This is an open access article under the Cet al., 1958). Reprogramming of mammalian somatic cells
has also been achieved using SCNT into oocytes, including
those of mice and humans (Noggle et al., 2011; Wakayama
et al., 1998). The procedure of SCNT into oocytes is similar
to iPSC generation with respect to the time course of
extinction of the parental gene-expression profile and acti-
vation of pluripotency (Egli et al., 2011). Both somatic cell
reprogramming processes involve dynamic rearrangement
of the epigenetic profile (Apostolou and Hochedlinger,
2013; Hussein et al., 2014). These findings suggest that
the constituents of oocytes include a reprogramming-pro-
moting factor. The linker histone H1 family binds to linker
DNA and generates higher-order chromatin structures
to control gene expression. Most members of the linker
histone family consist of somatic linker histones that
condense chromatin; therefore, these structures generally
repress global gene-transcription activity (Hebbar and
Archer, 2008; Steinbach et al., 1997). Mammalian oocytes
contain the maternal-specific linker histone H1foo, a ho-
molog of theXenopus linker histone B4.H1foo is specifically
expressed during the germinal vesicle stage and until the
late two-cell or early four-cell stage, coincident with the
early wave of zygotic genome reactivation (Gao et al.,
2004; Tanaka et al., 2003, 2005). In Xenopus SCNT, so-
matic linker histones in transplanted nuclei are rapidly
exchanged for linker histone B4, and the transplantedell Reports j Vol. 6 j 825–833 j June 14, 2016 j ª 2016 The Author(s) 825
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Exogenous Expression of H1foo Promotes iPSC Generation
(A) Immunostaining for H1foo (red), including nuclei stained with DAPI (blue) and bright-field (BF) images. Scale bar, 50 mm.
(B) Immunostaining for H1foo (red) with a 2D image (left) and a 2.5D image (right). The density of H1foo is depicted by the height in the
2.5D view. Scale bar, 5 mm.
(C) qRT-PCR analysis of endogenous H1foo expression during reprogramming, normalized by H1foo expression in H1foo-overexpressed MEFs
(n = 3 independent experiments).
(D) Alkaline phosphatase-positive iPSC colony formations for OSK, OSK with H1a (OSK + H1a; OSKA), OSK with H1c (OSK + H1c; OSKC), and
OSK with H1foo (OSK + H1foo; OSKH). Error bars represent the SEM (n = 3 independent experiments). *p < 0.05.
(legend continued on next page)
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nuclei begin to swell and initiate decondensation (Byrne
et al., 2003; Jullien et al., 2010); furthermore, in mouse
SCNT the same phenomenon is observed with H1foo
(Becker et al., 2005). Unlike other somatic linker histones,
B4 and H1foo do not restrict the accessibility of the linker
DNA, but decondense the chromatin and permit transcrip-
tional activation (Hayakawa et al., 2012; Saeki et al., 2005).
Based on these studies, we hypothesized that H1foo has
a beneficial effect on iPSC generation. Here, we show that
H1foo enhanced the generation of mouse iPSCs when co-
expressed with Oct4, Sox2, and Klf4. Furthermore, H1foo
promoted several in vitro differentiation characteristics
with low heterogeneity in iPSCs that were similar to those
of ESCs. Specifically, H1foo enhanced germline-competent
chimeric mouse generation. These findings indicate that
H1foo contributes to the generationof higher-quality iPSCs.RESULTS
Exogenous Expression of H1foo Promotes Qualified
iPSC Generation
We examined the effect of exogenousH1foo on somatic cell
reprogramming by introducing H1foo during iPSC genera-
tion with Oct4, Sox2, and Klf4 (OSK) or Oct4, Sox2, Klf4,
and c-Myc (OSKM). Retrovirus vector-mediated exogenous
H1foo was exclusively expressed in the nucleus of adult
mouse tail-tipfibroblasts (Figures1AandS1A) andhighly ex-
pressed peripherally in the nucleus (Figure 1B). SCNT into
oocytes induced swelling of nuclei and chromatin decon-
densation (Gao et al., 2004; Tamada et al., 2006; Teranishi
et al., 2004), so we investigated the effect ofH1foo on nuclei
(Figure S1B).We found thatH1a,H1c, andH1foohadno sig-
nificant effect on nuclear swelling (Figures S1C and S1D).
However, interestingly, only H1foo reduced the intensively
stained area, namely the heterochromatin area (Figure S1E).
Next, we addressed whether intrinsic H1foo might be ex-
pressed during iPSC generation from mouse embryonic
fibroblasts (MEFs) by introducing OSK or OSKM. However,
we did not observe detectable intrinsic H1foo expression
(Figure1C).Co-expressionofH1foowithOSK (OSKH) signif-
icantly enhanced the number of alkaline phosphatase-pos-
itive ESC-like colonies compared with OSK, OSK and H1a
(OSKA), or OSK and H1c (OSKC) (Figure 1D). The OSKH-
iPSCs expressed pluripotency markers similarly to control
iPSCs (OSK), and H1foo was silenced (Figure 1E). We then
examined the effect of H1foo on qualified iPSC generation(E) Immunostaining for pluripotency markers (OCT4 [green], SSEA1 [g
with DAPI (blue) in OSK-iPSCs and OSKH-iPSCs. Scale bars, 20 mm.
(F) Number of Nanog-GFP-positive iPSC colonies in each experiment (
(G) Proportion of Nanog-GFP-positive colonies to the total number of
experiments). *p < 0.05.using tail-tip fibroblasts from Nanog-GFP transgenic adult
mice (Okita et al., 2007) (Figure S1G). Interestingly, H1foo
also maximally promoted Nanog-GFP-positive colony gen-
eration (8-fold) during iPSC generation by OSK (Figure 1F).
Notably, H1foo specifically enhanced GFP-positive colonies
as opposed to GFP-negative colonies (Figure 1G).Characteristics of OSKH-iPSC Generation
Next, we examined the iPSC characteristics produced by
OSK and OSKH. The OSKH-iPSCs expressed pluripotency
markers similar to those ofOSK-iPSCs.Meanwhile the trans-
genes, includingH1foo, were silenced (Figure 2A). Regarding
the growth rate of iPSCs, there was no significant difference
between OSK- and OSKH-treated cells (Figure S1F). We
investigated the differences in global gene-transcriptome
profiles among ESCs, three replicates of OSK-iPSCs, and
four replicates ofOSKH-iPSCs.All cell typeswere remarkably
similar and showeda correlationcoefficient (R2) of 0.99 (Fig-
ures 2B and 2C). We then examined DNA demethylation
in the promoter regions of pluripotency marker genes (Fig-
ure S1H) and the differentiation potencies by teratoma
formation (Figure S1I). Furthermore, we focused on genes
differentially expressed between OSK-iPSCs and OSKH-
iPSCs. We chose eight differentially expressed genes, which
were statistically significant with more than a 2-fold
difference between OSK-iPSCs and OSKH-iPSCs (p < 0.05).
Many of the genes showedmore similar expression patterns
between OSKH-iPSCs and ESCs than between OSK-iPSCs
and ESCs (Figures S2A–S2H), but the expression levels of
these transcripts were heterogeneous among the replicates
in the same cell type, indicating that those genes would
not have a definitive role in stem cell properties. Although
a definitive marker that reflects the quality of iPSCs has
not been found, aberrant epigenetic silencing of the Dlk1-
Dio3 gene cluster could indicate developmental potency,
particularly because it contributes to the ratio of chimerism
in mouse iPSCs (Stadtfeld et al., 2010). We analyzed the
methylation status of an intergenic differentially methyl-
ated region (IG-DMR) that is located between the Dlk1 and
Gtl2 genes and a Gtl2 differentially methylated region
(Gtl2-DMR) (Figures 2D and 2E). Both loci in OSKH-iPSCs
were highly demethylated, similarly to ESCs and MEFs. We
next investigated the expression of several transcripts that
increase or diminish in the early reprogramming phase (Lu-
jan et al., 2015). Interestingly, OSKH-inducedMEFs showed
significant upregulation of several early reprogrammingreen], and Nanog [red]), including H1foo (red) and nuclei stained
n = 5 independent experiments).
ESC-like colonies. Error bars represent the SEM (n = 5 independent
Stem Cell Reports j Vol. 6 j 825–833 j June 14, 2016 827
Figure 2. Characteristics of OSKH-Induced iPSCs
(A) qRT-PCR analysis of pluripotency genes and H1foo in iPSCs. Error bars represent the SEM (n = 3 independent experiments).
(B and C) Pairwise scatterplots of global gene-expression cDNA microarray patterns of OSKH-iPSCs (n = 4) compared with ESC (n = 1) (B) or
OSK-iPSCs (n = 3) (C). The gray lines indicate log2 2-fold changes in gene-expression levels between the paired cell types.
(D and E) Degree of DNA methylation at IG-DMR and Gtl2-DMR in four OSK iPSC clones, four OSKH-iPSC clones, and ESCs, as well as MEFs
analyzed by pyrosequencing. Error bars represent the SEM (n = 3 independent experiments).markers (Figures S2I, S2J, and S2K) and downregulation of
fibroblast markers (Figures S2L and S2M) in comparison
with OSK- or OSKA-induced MEFs. We confirmed that
OSKH correctly traces the same pathway already reported.828 Stem Cell Reports j Vol. 6 j 825–833 j June 14, 2016H1foo Enhances the In Vitro Differentiation Potential
Next, we asked whetherH1foo could improve the quality of
iPSCs. Often iPSCs highly express pluripotency markers
but show poor differentiation efficiency in vitro, including
characteristics such as a low number of embryoid bodies
(EBs) and frazzled EBs with poor differentiation potential.
Moreover, this undesired trend is highly apparent in low-
passage iPSCs and is correlated to the remnant source cell
epigenetic memories (Kim et al., 2010; Polo et al., 2010).
We examined the differentiation potency by EB formation
in low-passage (P5) OSK-iPSCs, OSKH-iPSCs, and two types
of ESCs as controls. First, we examined the number and the
size of EBs at 5 days after differentiation (Figure S3A), which
were more similar between OSKH-iPSCs and ESCs than be-
tween OSK-iPSCs and ESCs (Figures 3A and 3B). Further-
more, the variance of EB size was smaller in OSKH-iPSCs
than in OSK-iPSCs (Figures 3C and 3D). OSKH-iPSCs ex-
pressed a higher content of proliferation markers than
OSK-iPSCs (Figures 3E and 3F). However, a significant dif-
ference was not observed in the differentiationmarker pro-
files amongESCs,OSK-iPSCs, andOSKH-iPSCs (Figure S3B).
We also examined the population of apoptotic cells during
differentiation. Apoptosis in OSKH-iPSCs was suppressed
compared with OSK-iPSCs (Figures 3G and S3C). Taken
together, the data suggest that H1foo causes iPSCs to be
more adaptable to in vitro differentiation conditions and
promotes the homogeneity of EBs.H1foo Enhances the In Vivo Differentiation Potential
Wefinally investigated the in vivo differentiation potential
of OSK-iPSCs and OSKH-iPSCs using a co-culture aggrega-
tion method (Eakin and Hadjantonakis, 2006). First we
examined the chromosome number, which showed no sig-
nificant difference in chromosomal abnormality between
OSK-iPSCs and OSKH-iPSCs (Figure 4A). Each iPSC clone
was aggregated with 100 ICR mouse embryos at the eight-
cell stage, and chimeric embryos were transferred into the
uteri of pseudopregnant females. Notably, OSKH-iPSCs
generated more live chimeras, with higher chimerism,
than OSK-iPSCs (Figures 4B, 4C, S4B, and S4C). Moreover,
some OSKH-iPSC clones generated more 100% chimeras
than ESCs (Figure S4B). Germline transmission potential
is one of the most stringent hallmarks of pluripotent
stem cells. We examined the germline transmission from
100% chimeric mice by in vitro fertilization. OSKH-iPSCs
generated many pups with colored coats, confirming the
favorable germline transmission potential of OSKH-iPSCs
(Figures 4E, S4D, and S4E).We did not find any phenotypic
abnormalities in these pups.DISCUSSION
H1foo promoted the generation of Nanog-GFP-positive col-
onies when it was co-expressed withOSK. Notably, the pro-
portion of GFP-positive colonies was improved to 90%.
OSKH-iPSCs demonstrated differentiation potency moresimilar to that of ESCs than did OSK-iPSCs, especially
with respect to in vitro EB formation, chimerism, and
germline transmission in vivo.We also examined the effect
ofH1foowithOct4, Sox2,Klf4, and c-Myc, but the number of
alkaline phosphatase-positive colonies and Nanog-GFP col-
onies, and the proportion of GFP-positive colonies were
not significantly different to those of OSKM-iPSCs. c-Myc
promotes iPSC generation but is not essential for reprog-
ramming. On the other hand, c-Myc lowers the proportion
ofNanog-GFP-positive colonies and increases the tumorige-
nicity of cells (Nakagawa et al., 2008). Therefore, it is pref-
erable to omit c-Myc in iPSC generation, although it is still
commonly used to promote reprogramming efficiency. We
showed here that H1foo could be substituted for c-Myc in
terms of reprogramming efficiency and showed superiority
with respect to qualifying iPSCs.
Recent studies have demonstrated that oocyte constitu-
ents play a key role in somatic cell reprogramming in
SCNT. Co-expression of maternal-specific factors in oo-
cytes, such as Glis1 (Maekawa et al., 2011) and TH2A/
TH2B (Shinagawa et al., 2014), enhances the reprogram-
ming efficiency of iPSC generation. Investigation of
maternal-specific factors in oocytes has great potential for
innovating somatic cell reprogramming and deciphering
the reprogramming mechanisms (Gurdon and Wilmut,
2011). H1foo is specifically expressed during the germinal
vesicle stage and is essential for oocyte maturation (Furuya
et al., 2007; Gao et al., 2004). Interestingly, exogenous
expression of H1foo in ESCs leads to the prevention of dif-
ferentiation in vitro due to continuous pluripotency gene
activation (Hayakawa et al., 2012). In our study, H1foo
was properly silenced in generated iPSCs, which induced
successful reprogramming but did not hinder the differen-
tiation potency of OSKH-iPSCs.
The detailedmolecularmechanisms regarding howH1foo
enhances the reprogramming efficiency in iPSC generation
and why OSKH-iPSCs exhibit improved quality remain
elusive. The higher-order chromatin structure is crucially
dependent on architectural chromatin proteins, including
the family of linkerhistoneproteins. Although somatic cells
contain numerous linker histone variants, only one, H1foo,
is present in mouse oocytes (Tanaka et al., 2001). In the
mouse egg, somatic linker histones in sperm-derived chro-
matin are rapidly replaced by H1foo after fertilization (Ta-
naka et al., 2001). In SCNT oocytes, the somatic linker his-
tone H1c in the donor chromatin is also rapidly replaced
by H1foo in mice (Gao et al., 2004; Teranishi et al., 2004).
In Xenopus SCNT, oocyte-specific linker histone B4 loading
to genome-wide somatic chromatin is required for success-
ful reprogramming (Jullien et al., 2010, 2014; Miyamoto
et al., 2007). In the early phase of the reprogramming pro-
cess, global loss of histone H3 lysine 27 trimethylation
(H3K27me3) occurs and epigenetic modification affectsStem Cell Reports j Vol. 6 j 825–833 j June 14, 2016 829
Figure 3. In Vitro Differentiation Potential in OSKH-iPSCs
(A) Number of EBs on day 5 after differentiation. Error bars represent the SEM (n = 3 independent experiments). *p < 0.05.
(B) Size of EBs on day 5 after differentiation. Error bars represent the SEM (n = 3 independent experiments). *p < 0.05.
(C) Variance of EB sizes from each ESCs and iPSCs (n = 3 independent experiments).
(D) Variation of EB sizes. Each bar represents one experiment.
(E and F) Cell-proliferation markers Ki67 (E) and proliferating cell nuclear antigen (PCNA; F) on day 2 after differentiation. Error bars
represent the SEM (n = 3 independent experiments). *p < 0.05.
(G) Apoptotic cell distribution determined by fluorescence-activated cell sorting analysis of cells labeled with annexin V-fluorescein
isothiocyanate and propidium iodide (PI) on day 1 after differentiation induction. Error bars represent the SEM (n = 3 independent
experiments). *p < 0.05.
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Figure 4. In Vivo Differentiation Potential in OSKH-iPSCs
(A) Chromosome number of each iPSC.
(B) Chimeric mice generated from OSK-iPSCs or OSKH-iPSCs.
(C) Number of agouti coat colored chimeric mice derived from each of four replicates of iPSCs.
(D) Birth rate of 100% chimeric mice (100% chimeric mice/embryos transferred).
(E) The coat color of pups from a 100% chimeric OSKH mouse shows germline transmission.the status of heterochromatin (Hussein et al., 2014). In our
study, H1foo reduced the heterochromatin area, which is
consistentwithprevious reports thatH1fookeeps chromatin
looser than somatic H1 and other linker histones, and may
support the generation of a more suitable chromatin state
for reprogramming. These data suggest that dominant occu-
pancy of oocyte-specific linker histone in donor chromatin
may be required for successful reprogramming and mighterase the parental epigenetic status. To determine whether
innate H1foo would cooperatively induce reprogramming
during iPSC generation byOSK, we examinedH1foo expres-
sion during iPSC generation by OSK. We did not detect
H1foo expression, which suggests thatH1foo is not essential
for OSK-dependent reprogramming. Therefore, we did not
perform loss-of-function experiments such as H1foo knock-
down by small interfering RNA.Stem Cell Reports j Vol. 6 j 825–833 j June 14, 2016 831
H1foo induced successful reprogramming for iPSC gener-
ation in a stringent assay, thus contributing to chimerism
and germline transmission. Although in vivo experiments
cannot be performed inhumans, it is important to generate
high-quality iPSCs without variation among different iPSC
lines.EXPERIMENTAL PROCEDURES
Details of all procedures are available in Supplemental Experi-
mental Procedures.
All experiments were performed in accordance with the Keio
University Animal Care Guidelines and were approved by the
Ethics Committee of Keio University (20-041-4), which conforms
to the Guide for the Care andUse of Laboratory Animals published
by the US National Institutes of Health.
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The accession number for the microarray data reported in this pa-
per is GEO: GSE79515.
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